Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 3/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.47 |
| ▸ | HTR3B | O95264 | 1/20 | 0.47 |
| ▸ | HTR3A | P46098 | 1/20 | 0.47 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.47 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.47 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91132 | 0.98 | TAAR1 (0.60) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| Formaldehyde SCHEMBL27848039 | 0.91 | TAAR1 (0.54) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| Ammonia Solution, Strong SCHEMBL9427687 | 0.86 | TAAR1 (0.54) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL256701 | 0.84 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL1374203 | 0.82 | LIPG (0.55) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| Ammonia Solution, Strong SCHEMBL14718471 | 0.82 | TAAR1 (0.61) | TAAR1SLC6A2SLC6A4SLC6A3IDO1 | |
| SCHEMBL6740216 | 0.82 | TAAR1 (0.71) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL3694247 | 0.80 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL5599139 | 0.80 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL5271594 | 0.80 | LIPG (0.58) | TAAR1SLC6A2SLC6A4SLC6A3AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | TAAR1 1746/4885SLC6A2 2280/4885SLC6A4 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.